Medtronic Gets FDA OK To Start Pivotal Trial Of CoreValve
This article was originally published in The Gray Sheet
Executive Summary
Medtronic has gained conditional approval from FDA to begin the pivotal trial of its CoreValve transcatheter aortic valve system in the United States, the firm announced Oct. 15.